These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China. Zhang H, Yin Y, Zhang C, Zhang D. BMC Health Serv Res; 2019 Sep 18; 19(1):671. PubMed ID: 31533714 [Abstract] [Full Text] [Related]
6. Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender. Sánchez-Muñoz G, Lopez-de-Andrés A, Hernández-Barrera V, Jiménez-García R, Pedraza-Serrano F, Puente-Maestu L, de Miguel-Díez J. PLoS One; 2019 Sep 18; 14(1):e0211222. PubMed ID: 30682190 [Abstract] [Full Text] [Related]
7. Hospitalization costs of COPD cases and its associated factors: an observational study at two large public tertiary hospitals in Henan Province, China. Yu C, Xia Q, Li Q, Wu J, Wang X, Wu J. BMC Geriatr; 2023 Jul 25; 23(1):457. PubMed ID: 37491188 [Abstract] [Full Text] [Related]
8. Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017. Liang L, Shang Y, Xie W, Shi J, Tong Z, Jalali MS. Int J Chron Obstruct Pulmon Dis; 2020 Jul 25; 15():1165-1175. PubMed ID: 32547004 [Abstract] [Full Text] [Related]
9. COPD: Does Inpatient Education Impact Hospital Costs and Length of Stay? Hosseini HM, Pai DR, Ofak DR. Hosp Top; 2019 Jul 25; 97(4):165-175. PubMed ID: 31621519 [Abstract] [Full Text] [Related]
10. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization. Terzano C, Colamesta V, Unim B, Romani S, Meneghini A, Volpe G, La Torre G. Eur Rev Med Pharmacol Sci; 2017 Aug 25; 21(16):3680-3689. PubMed ID: 28925473 [Abstract] [Full Text] [Related]
11. Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam. Ngo CQ, Thi Bui T, Vu GV, Chu HT, Phan PT, Ngoc Pham H, Vu GT, Nguyen LH, Ha GH, Tran BX, Latkin CA, Ho CSH, Ho RCM. Int J Environ Res Public Health; 2018 Dec 30; 16(1):. PubMed ID: 30598020 [Abstract] [Full Text] [Related]
12. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L. Am J Geriatr Pharmacother; 2008 Aug 30; 6(3):138-46. PubMed ID: 18775388 [Abstract] [Full Text] [Related]
13. Factors associated with hospitalisation costs in patients with chronic obstructive pulmonary disease. Li F, Sun Z, Li H, Yang T, Shi Z. Int J Tuberc Lung Dis; 2018 Apr 01; 22(4):458-463. PubMed ID: 29562996 [Abstract] [Full Text] [Related]
14. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Schwab P, Dhamane AD, Hopson SD, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S. Int J Chron Obstruct Pulmon Dis; 2017 Apr 01; 12():735-744. PubMed ID: 28260880 [Abstract] [Full Text] [Related]
16. [Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations]. Targowski T, Jahnz-Rózyk K, From S, Płusa T. Pneumonol Alergol Pol; 2005 Apr 01; 73(1):32-5. PubMed ID: 16539181 [Abstract] [Full Text] [Related]
18. Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China. Zhang J, Yao W, You X, Liu T, Liu Y. Int J Chron Obstruct Pulmon Dis; 2019 Apr 01; 14():1195-1207. PubMed ID: 31213797 [Abstract] [Full Text] [Related]